Invesco Portfolio holdings
Invesco Ltd., founded in 1978 and headquartered in Atlanta, Georgia, is a global investment management firm managing hundreds of billions in assets across a diverse range of products, including mutual funds, exchange-traded funds (ETFs), and institutional portfolios. Known for its blend of active and passive investment strategies, Invesco serves individual investors, financial advisors, and institutions, with a strong presence in North America, Europe, and Asia, bolstered by acquisitions like OppenheimerFunds in 2019. The firm offers specialized solutions in equities, fixed income, real estate, and alternatives, leveraging its global research capabilities to cater to varying market needs. Invesco’s commitment to innovation and client-focused investing has solidified its reputation as a versatile player in the asset management industry.
Top Buys
| 1 |
Palo Alto Networks
PANW
|
$726M |
| 2 |
Apple
AAPL
|
$661M |
| 3 |
Oracle
ORCL
|
$522M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
$482M |
| 5 |
Microsoft
MSFT
|
$464M |
Top Sells
| 1 |
Meta Platforms (Facebook)
META
|
$569M |
| 2 |
Intuit
INTU
|
$427M |
| 3 |
HEICO Class A
HEI.A
|
$334M |
| 4 |
Yum China
YUMC
|
$273M |
| 5 |
Stellantis
STLA
|
$256M |
Sector Composition
| 1 | Technology | 22.35% |
| 2 | Healthcare | 12.7% |
| 3 | Financials | 11.41% |
| 4 | Industrials | 11.17% |
| 5 | Consumer Discretionary | 10.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3651
P3 Health Partners
PIII
$28.7M
| $48.6K | ﹤0.01% |
325
+71
| +28% | +$10.6K |
|
|
PSTX
3652
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $48.6K | ﹤0.01% |
+27,600
| New | +$48.6K |
|
|
OPTN
3653
DELISTED
OptiNose
OPTN
| $48K | ﹤0.01% |
+2,603
| New | +$48K |
|
3654
Atara Biotherapeutics
ATRA
$90.7M
| $46.5K | ﹤0.01% |
1,154
-143
| -11% | -$5.76K |
|
3655
Vor Biopharma
VOR
$248M
| $44.9K | ﹤0.01% |
+14,523
| New | +$44.9K |
|
|
LPTV
3656
DELISTED
Loop Media, Inc.
LPTV
| $44.5K | ﹤0.01% |
+18,616
| New | +$44.5K |
|
3657
Protalix BioTherapeutics
PLX
$123M
| $43.3K | ﹤0.01% |
+21,652
| New | +$43.3K |
|
3658
Veritone
VERI
$147M
| $42.7K | ﹤0.01% |
10,889
-324
| -3% | -$1.27K |
|
|
NNDM
3659
Nano Dimension
NNDM
$293M
| $41.8K | ﹤0.01% |
14,452
-3,887
| -21% | -$11.2K |
|
|
AMRN
3660
Amarin Corp
AMRN
$311M
| $41.3K | ﹤0.01% |
1,734
+686
| +65% | +$16.3K |
|
3661
Paysign
PAYS
$286M
| $40.9K | ﹤0.01% |
+16,674
| New | +$40.9K |
|
|
TGAN
3662
DELISTED
Transphorm, Inc. Common Stock
TGAN
| $40.5K | ﹤0.01% |
11,914
+1,198
| +11% | +$4.07K |
|
3663
Ocugen
OCGN
$322M
| $39.8K | ﹤0.01% |
73,249
-3,367
| -4% | -$1.83K |
|
|
VRAY
3664
DELISTED
ViewRay, Inc.
VRAY
| $38.4K | ﹤0.01% |
109,133
+39,565
| +57% | +$13.9K |
|
3665
Trevi Therapeutics
TRVI
$854M
| $38.4K | ﹤0.01% |
+16,046
| New | +$38.4K |
|
|
KLRS
3666
Kalaris Therapeutics, Inc. Common Stock
KLRS
$86.4M
| $36.3K | ﹤0.01% |
465
-47
| -9% | -$3.67K |
|
3667
Esperion Therapeutics
ESPR
$540M
| $36.1K | ﹤0.01% |
25,949
-4,265
| -14% | -$5.93K |
|
3668
Precigen
PGEN
$1.3B
| $36K | ﹤0.01% |
31,313
-99,759
| -76% | -$115K |
|
|
GTHX
3669
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $34.7K | ﹤0.01% |
13,925
+1,010
| +8% | +$2.52K |
|
|
AEVA
3670
Aeva Technologies
AEVA
$786M
| $34.2K | ﹤0.01% |
5,465
-1,417
| -21% | -$8.86K |
|
|
GRTX
3671
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
| $33.8K | ﹤0.01% |
+10,839
| New | +$33.8K |
|
3672
CytomX Therapeutics
CTMX
$376M
| $33.5K | ﹤0.01% |
19,458
+6,393
| +49% | +$11K |
|
3673
Kezar Life Sciences
KZR
$29.8M
| $32.8K | ﹤0.01% |
1,340
-246
| -16% | -$6.03K |
|
|
ADAP
3674
Adaptimmune Therapeutics
ADAP
$10.9M
| $32.4K | ﹤0.01% |
+34,992
| New | +$32.4K |
|
3675
BigBear.ai
BBAI
$1.85B
| $32.2K | ﹤0.01% |
+13,713
| New | +$32.2K |
|